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ABSTRACT
Background and Aims It has been proposed that more use should be made of Bayes factors in hypothesis testing in ad-
diction research. Bayes factors are the ratios of the likelihood of a speciﬁed hypothesis (e.g. an intervention effect within a
given range) to another hypothesis (e.g. no effect). They are particularly important for differentiating lack of strong evi-
dence for an effect and evidence for lack of an effect. This paper reviewed randomized trials reported in Addiction between
January and June 2013 to assess how far Bayes factors might improve the interpretation of the data.Methods Seventy-
ﬁve effect sizes and their standard errors were extracted from 12 trials. Seventy-three per cent (n = 55) of these were non-
signiﬁcant (i.e. P> 0.05). For each non-signiﬁcant ﬁnding a Bayes factor was calculated using a population effect derived
from previous research. In sensitivity analyses, a further two Bayes factors were calculated assuming clinically meaningful
and plausible ranges around this population effect.Results Twenty per cent (n= 11) of the non-signiﬁcant Bayes factors
were< ⅓ and 3.6% (n = 2) were> 3. The other 76.4% (n = 42) of Bayes factors were between⅓ and 3. Of these, 26 were
in the direction of there being an effect (Bayes factor> 1 and< 3); 12 tended to favour the hypothesis of no effect (Bayes
factor < 1 and > ⅓); and for four there was no evidence either way (Bayes factor = 1). In sensitivity analyses, 13.3% of
Bayes Factors were < ⅓ (n = 20), 62.7% (n = 94) were between ⅓ and 3 and 24.0% (n = 36) were > 3, showing good
concordance with the main results. Conclusions Use of Bayes factors when analysing data from randomized trials of in-
terventions in addiction research can provide important information that would lead to more precise conclusions than are
obtained typically using currently prevailing methods.
Keywords Addiction, Bayes factors, Bayesian, hypothesis testing, non-signiﬁcant, RCT.
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INTRODUCTION
Bayesian statistical analyses are being used increasingly in
addictions research, and it has been proposed that this
trend should accelerate [1]. One important component of
Bayesian analysis is the calculation of Bayes factors, which
overcome many of the problems of traditional frequentist
statistics [2]. One of these is the misinterpretation that P-
values can be used to make claims of ‘no effect’ [3–5].
P-values signal the extremeness of the data under the as-
sumption of the null hypothesis and so only tell us the
probability of a test statistic at least as extreme as the one
observed [6]. Thus, a P > 0.05 may reﬂect evidence for
‘no effect’ or data insensitivity, i.e. a failure to distinguish
the null hypothesis from the alternative because, for
example, the standard error (SE) is high.
Bayes factors are the ratio of the (average) likelihood of
two hypotheses being correct given a set of data. When
evaluating interventions, the two hypotheses are typically
H1: that the intervention had a desired effect (for a given
range of plausible sizes), or within a certain range, versus
H0: that it had no effect. Thus, a Bayes factor is equivalent
to a likelihood ratio [7] (averaged over different plausible
effect sizes) and thus is often denoted as:
Bayes Factor¼ likelihood of data given H1
likelihood of data given H0
¼ P D H1jð Þ
P D H0jð Þ
which simply represents the probability of the data (D)
given the alternative hypothesis divided by the probability
of the data given the null hypothesis.
The use of Bayes factors has becomemore feasible in re-
cent years following the development of online calculators
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[8] and R code [9,10]. Conventional cut-offs for the inter-
pretation of Bayes factors depend typically upon those set
by Jeffreys [2] in the 1930s, with a Bayes factor greater
than 3, or else less than⅓, representing sufﬁcient evidence
to be taken note of for the experimental and null hypothe-
ses, respectively; while values between approximately ⅓
and 3 indicate that the data are insensitive (see Table 1).
This paper uses a set of randomized trials in the ﬁeld of
addiction to examine whether, and in what way, the con-
clusions may have been different had the authors calcu-
lated Bayes factors in their analyses. This should be useful
in future research to assess whether and when to use this
form of analysis.
CALCULATING BAYES FACTORS
Several software packages are available including an online
calculator developed by Zoltan Dienes (http://www.lifesci.
sussex.ac.uk/home/Zoltan_Dienes/inference/Bayes.htm)
and amodiﬁed version by JohnChristie usingR code,which
allows one to adjust the quality of the estimation [9,10].
Both approaches require the speciﬁcation of an ex-
pected effect size (i.e. a plausible range of predicted values
based on previous studies, judgement or clinical signiﬁ-
cance), the published effect size (e.g. mean difference or
log odds ratio) and standard error of this parameter. They
also both assume that the sampling distribution of the pa-
rameter estimate is distributed normally (hence the need
to use the natural logs of odds ratios). The natural log of
the odds ratio is approximately normally distributed with
known standard error given by
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
A þ 1B þ 1C þ 1D
q
, where A
is the number of individuals in the experimental condition
with the outcome of interest, B is the number of individuals
in the experimental condition without the outcome of in-
terest and C and D reﬂect the number of individuals with
and without the outcome of interest in the control condi-
tion respectively (i.e. odds ratio = (A/B)/(C/D)), provided
that these numbers are not very small. For adjusted odds
ratios, and/or where standard errors (SE) are not
reported, 95% conﬁdence intervals (CI) can be used to
derive the standard error {i.e. [LN(upper conﬁdence inter-
val)–LN(lower conﬁdence interval)]/3.92}.
In instances where the primary outcome measure is a
continuous variable, SEs can be derived for mean differ-
ences or regression coefﬁcients (β) either using the stan-
dard formula for the SE of mean difference, i.e. [(SD2control/
nControl) + (SD
2
experimental/nexperimental)]; or t-test values
using [mean difference (or β)/t-test value]; or (3) 95%
CI = {[LN(upper conﬁdence interval)–LN(lower conﬁdence
interval)]/3.92}.
A worked example, using the calculator associated
with Dienes, can be found in Supporting information,
Appendix 1.
Others have advocated alternative methods of comput-
ing Bayes factors, including the Jeffreys–Zellner–Siow (JZS)
t-test [4,12], which can be implemented in R [13,14] (see
Dienes & McLatchie, submitted, for comparison). Moves
have also been made towards full Bayesian modelling,
which requires a much more advanced knowledge of R
or specialist software packages, and is beyond the scope of
the current paper (e.g. WinBUGS) [3,11].
METHODS
Bayes factors were calculated for 12 randomized controlled
trials published in theﬁrst six issues ofAddiction in2013 (be-
tween January and June). Effect sizes, SEs,P–values and the
mainconclusionsdrawnbytheauthorswereextracted from
the papers for both primary andmain secondaryoutcomes.
Studiesaregenerallyonlypoweredtodetect estimateddiffer-
ences between experimental and control groups for the pri-
mary outcome, and thus Bayes factors may be particularly
useful for secondary analyses [15,16]. Concerns have been
raised previously regarding the interpretation of non-
signiﬁcant ﬁndings for sensitivity analyses [15,16].
Adjusted effect sizes (where available) and those re-
ported at the longest point of follow-up were used. Bayes
factors were calculated using the online calculator pro-
vided by Dienes [8] and the modiﬁed version using R code
by Christie [9,10]. Predicted values for the effect size or
population standard deviation (SD) were based on previous
studies (see Table 2). Additional sensitivity analyses were
run to assess the effect of using higher and lower values.
The chosen range was based either on the reported CI of
Table 1 Jeffreys’ Bayes factor cut-offs.
Bayes factor Interpretation
> 100 Extreme evidence for the experimental
hypothesis
30–100 Very strong evidence for the experimental
hypothesis
10–30 Strong evidence for the experimental
hypothesis
3–10 Moderate evidence for the experimental
hypothesis
1–3 Anecdotal evidence for the experimental
hypothesis
1 No evidence
⅓–1 Anecdotal evidence for the null hypothesis
⅓–1/10 Moderate evidence for the null hypothesis
1/10–1/30 Strong evidence for the null hypothesis
1/30–1/100 Very strong evidence for the null hypothesis
< 1/100 Extreme evidence for the null hypothesis
The original label for 3< Bayes factor< 10was ‘substantial evidence’. Lee &
Wagenmakers changed it to moderate, as they thought the original label
sounded too decisive [3,11].
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the predicted effect size selected from previous publications
or, when not available, the opinion of the lead author as to
what would be a plausible effect.
When specifying the predicted effect, we used a ‘half
normal distribution’ whose peak was at 0 (no effect) and
extending upwards with a SD equal to the expected effect
size. This represents a hypothesis that the intervention
had at least some positive effect, with the effect being more
likely to be smaller than larger. This is a conservative ap-
proach to prediction. Another approach would be to spec-
ify the hypothesis as a uniform distribution between 0 (or a
minimally clinically signiﬁcant value) and a plausible up-
per bound. Given that none of the authors of the studies
reviewed indicated what they considered to be a clinically
meaningful effect or a plausible upper bound for the effect
size, we took the conservative approach.
RESULTS
Of the 12 studies, 55 non-signiﬁcant effects and 20 signif-
icant effects were reported. For each of these, three Bayes
factors were calculated: one based on an expected popula-
tion SD (identiﬁed from previous studies) and two based on
a range of values around the expected population SD (iden-
tiﬁed from previous studies or based on expert opinion).
Thus, a total of 75 Bayes factors were calculated in the
main analysis and 150 Bayes factors were derived in the
sensitivity analysis (see Table 2).
Fifty-six per cent (n = 42) of the Bayes factors were be-
tween ⅓ and 3; 14.7% (n = 11) were < ⅓ and 29.3%
(n = 22) were > 3. When considering only the non-
signiﬁcant ﬁndings (n = 55), 20.0% (n = 11) of Bayes fac-
tors were < ⅓ and 3.6% (n = 2) were > 3. The other
76.4% (n = 42) of Bayes factors were between ⅓ and 3.
Of these, 26 were in the direction of there being an effect
(Bayes factor > 1 and < 3); 12 tended to favour the hy-
pothesis of no effect (Bayes factor < 1 and > ⅓); and for
four there was no evidence either way (Bayes factor = 1).
In sensitivity analyses, 13.3% of Bayes factors were<⅓
(n=20), 62.7% (n=94)were between⅓ and 3 and 24.0%
(n = 36) were >3, showing good consistency with the
main results.
Authors either decided not to discuss results where
P> 0.05, to report them as non-signiﬁcant and/or to state
that no association was found. Good concordance was
noted between the online calculator [8] and the adapted
R code [9], except for those Bayes factors that indicated ex-
treme evidence for the experimental hypothesis.
DISCUSSION
Only ⅕ of all non-signiﬁcant ﬁndings provided support for
the hypothesis of no effect, while nearly ⅔ of the Bayes
factors indicated data insensitivity. Thus, reporting ‘no dif-
ference’ between conditions or lack of associations was ap-
propriate for only a small number of papers. A minority of
Bayes factors for the non-signiﬁcant effects also supported
the experimental hypothesis; this tended to occur with P-
values close to statistical signiﬁcance.
The development of online calculators and R code
[9,10] means that researchers in the addiction ﬁeld can
calculate Bayes factors easily to include as an adjunct
to traditional frequentist results. The requirement to
specify the experimental hypothesis means that scientiﬁc
judgement is needed. This is a common criticism of
Bayesian type methods [17], but it can also be a poten-
tial strength, because it forces researchers to be speciﬁc
about what it is they are testing. Moreover, if there are
differences of view about what may be plausible values
of the effect size, it is a simple matter to conduct sensitiv-
ity analyses to assess what, if any, difference this makes.
As a rule of thumb, if one is interested in a clinically
relevant range then the uniform distribution can be
speciﬁed; alternatively, one can use a half-normal distri-
bution with the peak at 0 if one is interested in any
effect at all and has little conﬁdence in the probable
value. To prevent researcher bias, pre-speciﬁed analysis
plans may be published which detail the method which
will be used to calculate Bayes factors, the cut-off
values for interpretation and the plausible effect size
which is expected.
The ﬁndings of this review show that researchers
should avoid the use of terms such as ‘no difference’ or
‘lack of associations’ for P-values > 0.05, unless a Bayes
factor < 0.3 is also found. Otherwise null ﬁndings should
be framed as ‘the ﬁndings were inconclusive as to whether
or not a difference/association was present’, or some simi-
lar wording. This is now encouraged practice by the Addic-
tion journal [1]. Researchers may also wish to use Bayes
factors in order to quantify the evidence for the experimen-
tal hypothesis (i.e. moderate, strong, very strong and ex-
treme) and/or use such a calculation as a stopping rule
for data collection [18]. For ethical and perhaps ﬁnancial
reasons interim analyses are often planned for randomized
trials, with early stopping occurring if there is demon-
strated efﬁcacy, the intervention is harmful or there is no
beneﬁcial effect. P-values cannot inform about us about
the latter; in contrast, a Bayes factor indicating data insen-
sitivity would suggest further recruitment, while a Bayes
factor indicating evidence for the null hypothesismay point
towards early termination.
Note that the methods used to derive Bayes factors in
this paper did not cover all the possibilities. More ad-
vanced Bayesian hierarchical modelling (BHM) [11], im-
plemented in R and winBUGS, allows a wider range of
distributions, e.g. gamma, Poisson, binomial and negative
binomial.
Using Bayes factors for testing hypotheses about intervention effectiveness in addictions research 2245
© 2016 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction Addiction, 111, 2230–2247
Declaration of interests
E.B. has received unrestricted funding from Pﬁzer. R.W.
undertakes consultancy and research for and receives
travel funds and hospitality from manufacturers of
smoking cessation medications but does not, and will
not, take funds from EC manufacturers or the tobacco in-
dustry. R.W. is an advisor to the National Centre for
Smoking Cessation Z.D. has no conﬂicts of interest to
declare.
Acknowledgements
R.W.’s salary is funded by Cancer Research UK (CRUK). E.B.
is funded by CRUK and by the National institute for Health
Research (NIHR)’s School for Public Health Research
(SPHR). The views are those of the author(s) and not nec-
essarily those of the NHS, the NIHR or the Department of
Health. SPHR is a partnership between the Universities of
Shefﬁeld; Bristol; Cambridge; Exeter; UCL; The London
School for Hygiene and Tropical Medicine; the LiLaC
collaboration between the Universities of Liverpool and
Lancaster and Fuse; The Centre for Translational Research
in Public Health, a collaboration between Newcastle,
Durham, Northumbria, Sunderland and Teesside
Universities. CM has nothing to declare.
References
1. West R. Using Bayesian analysis for hypothesis testing in ad-
diction science. Addiction 2016; 111: 3–4.
2. Jeffreys H. Theory of Probability. Oxford: Clarendon Press;
1961.
3. Wagenmakers E.-J. A practical solution to the pervasive prob-
lems of p values. Psychon Bull Rev 2007; 14: 779–4.
4. Rouder J. N., Speckman P. L., Sun D., Morey R. D., Iverson G.
Bayesian t-tests for accepting and rejecting the null hypothe-
sis. Psychon Bull Rev 2009; 16: 225–37.
5. Gallistel C. The importance of proving the null. Psychol Rev
2009; 116: 439.
6. SchervishM. J. P values: what they are andwhat they are not.
Am Statistician 1996; 50: 203–6.
7. Berger J. O. Statistical Decision Theory and Bayesian Analysis.
Berlin: Springer Science and Business Media; 2013.
8. Dienes Z. Using Bayes to get themost out of non-signiﬁcant re-
sults. Front Psychol 2014; 5: 781.
9. Bayes C. J. Factor Calculator. R code 2011. Available at:
http://www.lifesci.sussex.ac.uk/home/Zoltan_Dienes/inference/
bayesFactorCalc2.R (accessed 1 March 2016).
10. Baguley T., KayeW. S. Reviewof understanding psychology as
a science: an introduction to scientiﬁc and statistical infer-
ence. Br J Math Stat Psychol 2010; 63: 695–8.
11. Lee M., Wagenmakers E. Bayesian Modeling for Cognitive Sci-
ence: A Practical Course. Cambridge: Cambridge University
Press; 2013.
12. Rouder J. N., Morey R. D., Speckman P. L., Province J. M. De-
fault Bayes factors for ANOVA designs. J Math Psychol
2012; 56: 356–74.
13. Baguley T. Serious Stats: A Guide to Advanced Statistics for the
Behavioral Sciences. Basingstoke: Palgrave Macmillan; 2012.
14. Morey R., Rouder J., Jamil T. Bayes Factor: computation of
Bayes factors for common designs. R package version 09.
2014; 8. Available from: https://cran.r-project.org/web/pack-
ages/BayesFactor/BayesFactor.pdf (accessed 1 March 2016).
15. Koch M., Riss P., Umek W., Hanzal E. The primary outcomes
and power calculations in clinical RCTs in urogynecology—
need for improvement? Trials 2015; 16: 1.
16. Freemantle N. Interpreting the results of secondary end points
and subgroup analyses in clinical trials: should we lock the
crazy aunt in the attic? BMJ 2001; 322: 989–91.
17. Sprenger J. The Objectivity of Subjective Bayesian Inference
2015. Available at: http://philsci-archive.pitt.edu/11936/1/
ObjectiveBayesianStatistics_v3.pdf (accessed 1 March 2016).
18. Rouder J. N. Optional stopping: no problem for Bayesians.
Psychon Bull Rev 2014; 21: 301–8.
19. Kypri K., McCambridge J., Vater T., Bowe S. J., Saunders J. B.,
Cunningham J. A. et al. Web-based alcohol intervention for
Māori university students: double-blind, multi-site random-
ized controlled trial. Addiction 2013; 108: 331–8.
20. Li L., Wu Z., Liang L. J., Lin C., Zhang L., Guo S. et al.An inter-
vention targeting service providers and clients for methadone
maintenance treatment in China: a cluster-randomized trial.
Addiction 2013; 108: 356–66.
21. Ward K. D., Asfar T., Ali A. R., Rastam S., Weg M. W. V.,
Eissenberg T. et al. Randomized trial of the effectiveness of
combined behavioral/pharmacological smoking cessation
treatment in Syrian primary care clinics. Addiction 2013;
108: 394–3.
22. Borland R., Balmford J., Benda P. Population-level effects of
automated smoking cessation help programs: a randomized
controlled trial. Addiction 2013; 108: 618–28.
23. Rendall-Mkosi K., Morojele N., London L., Moodley S., Singh
C., Girdler-Brown B. A randomized controlled trial of motiva-
tional interviewing to prevent risk for an alcohol-exposed
pregnancy in the Western Cape, South Africa. Addiction
2013; 108: 725–32.
24. Cofﬁn P. O., Santos G. M., Das M., Santos D. M., Huffaker
S., Matheson T. et al. Aripiprazole for the treatment of
methamphetamine dependence: a randomized, double-
blind, placebo-controlled trial. Addiction 2013; 108:
751–61.
25. Gilbert H. M., Leurent B., Sutton S., Alexis-Garsee C., Morris
R. W., Nazareth I. ESCAPE: a randomised controlled trial of
computer-tailored smoking cessation advice in primary care.
Addiction 2013; 108: 811–9.
26. Alessi S. M., Petry N. M. A randomized study of cellphone
technology to reinforce alcohol abstinence in the natural en-
vironment. Addiction 2013; 108: 900–9.
27. Richmond R., Indig D., Butler T., Wilhelm K., Archer V.,
Wodak A. A randomized controlled trial of a smoking cessa-
tion intervention conducted among prisoners. Addiction
2013; 108: 966–74.
28. Levin F. R., Mariani J., Brooks D. J., Pavlicova M., Nunes E. V.,
Agosti V. et al. A randomized double-blind, placebo-controlled
trial of venlafaxine-extended release for co-occurring canna-
bis dependence and depressive disorders. Addiction 2013;
108: 1084–94.
29. Okuyemi K. S., Goldade K., Whembolua G. L., Thomas J. L.,
Eischen S., Sewali B. et al. Motivational interviewing to en-
hance nicotine patch treatment for smoking cessation
among homeless smokers: a randomized controlled trial.
Addiction 2013; 108: 1136–44.
30. Gustafson D. H., Quanbeck A. R., Robinson J. M., Ford J. H.,
Pulvermacher A., French M. T. et al. Which elements of
2246 Emma Beard et al.
© 2016 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction Addiction, 111, 2230–2247
improvement collaboratives are most effective? A cluster-
randomized trial. Addiction 2013; 108: 1145–57.
31. Kypri K., Hallett J., Howat P., McManus A., Maycock B., Bowe
S. et al. Randomized controlled trial of proactive web-based al-
cohol screening and brief intervention for university students.
Arch Intern Med 2009; 169: 1508–14.
32. Andrews S., Sorensen J. L., Guydish J., Delucchi K., Greenberg
B. Knowledge and attitudes about methadone maintenance
among staff working in a therapeutic community. J Mainten
Addict 2005; 3: 47–59.
33. Livingston J. D., Milne T., Fang M. L., Amari E. The effective-
ness of interventions for reducing stigma related to
substance use disorders: a systematic review. Addiction
2012; 107: 39–50.
34. Hser Y.-I. Predicting long-term stable recovery from heroin
addiction: ﬁndings from a 33-year follow-up study. J Addict
Dis 2007; 26: 51–60.
35. Mattick R. P., Breen C., Kimber J., Davoli M. Methadone
maintenance therapy versus no opioid replacement ther-
apy for opioid dependence. Cochrane Database Syst Rev
2009; 3.
36. Stead L. F., Perera R., Bullen C., Mant D., Lancaster T. Nicotine
replacement therapy for smoking cessation.Cochrane Database
Syst Rev 2008; 1: CD000146.
37. Floyd R. L., Sobell M., Velasquez M. M., Ingersoll K.,
Nettleman M., Sobell L. et al. Preventing alcohol-exposed
pregnancies: a randomized controlled trial. Am J Prev Med
2007; 32: 1–10.
38. Ingersoll K. S., Ceperich S. D., Nettleman M. D., Karanda K.,
Brocksen S., Johnson B. A. Reducing alcohol-exposed preg-
nancy risk in college women: initial outcomes of a clinical
trial of a motivational intervention. J Subst Abuse Treat
2005; 29: 173–80.
39. Tiihonen J., Kuoppasalmi K., Föhr J., Tuomola P., Kuikanmäki
O., VormaH. et al.A comparison of aripiprazole, methylpheni-
date, and placebo for amphetamine dependence. Am J
Psychiatry 2007; 164: 160–2.
40. Colfax G. N., Santos G.-M., Das M., Santos D. M., Matheson T.,
Gasper J. et al.Mirtazapine to reduce methamphetamine use:
a randomized controlled trial. Arch Gen Psychiatry 2011; 68:
1168–75.
41. Meini M., Moncini M., Cecconi D., Cellesi V., Biasci L.,
Simoni G. et al. Aripiprazole and ropinirole treatment for
cocaine dependence: evidence from a pilot study. Curr Pharm
Des 2011; 17: 1376–83.
42. Lancaster T., Stead L. F. Self-help interventions for smoking
cessation. Cochrane Database Syst Rev 2005; 3: CD001007.
43. Petry N. M., Martin B., Cooney J. L., Kranzler H. R. Give them
prizes and they will come: contingency management for
treatment of alcohol dependence. J Consult Clin Psychol
2000; 68: 250.
44. Barnett N. P., Tidey J., Murphy J. G., Swift R., Colby S. M. Con-
tingency management for alcohol use reduction: a pilot study
using a transdermal alcohol sensor. Drug Alcohol Depend
2011; 118: 391–9.
45. Litt M. D., Kadden R. M., Kabela-Cormier E., Petry N. M.
Changing network support for drinking: network support pro-
ject 2-year follow-up. J Consult Clin Psychol 2009; 77: 229.
46. Hughes J. R., Stead L. F., Hartmann-Boyce J., Cahill K.,
Lancaster T. Antidepressants for smoking cessation. Cochrane
Database Syst Rev 2014; 1: CD000031.
47. Findling R. L., PaganoM. E., McNamara N. K., Stansbrey R. J.,
Faber J. E., Lingler J. et al. The short-term safety and efﬁcacy of
ﬂuoxetine in depressed adolescents with alcohol and cannabis
use disorders: a pilot randomized placebo-controlled trial.
Child Adolesc Psychiatr Ment Health 2009; 3: 11.
48. Keller M. B., Trivedi M. H., Thase M. E., Shelton R. C.,
Kornstein S. G., Nemeroff C. B. et al. The Prevention of Re-
current Episodes of Depression with Venlafaxine for Two
Years (PREVENT) Study: outcomes from the 2-year and
combined maintenance phases. J Clin Psychiatry 2007;
68: 1246–56.
49. Bonnet U., Specka M., Stratmann U., Ochwadt R.,
Scherbaum N. Abstinence phenomena of chronic
cannabis-addicts prospectively monitored during controlled
inpatient detoxiﬁcation: Cannabis withdrawal syndrome
and its correlation with delta-9-tetrahydrocannabinol and-
metabolites in serum. Drug Alcohol Depend 2014; 143:
189–97.
50. Smeerdijk M., Keet R., Dekker N., van Raaij B., Krikke M.,
Koeter M. et al. Motivational interviewing and interaction
skills training for parents to change cannabis use in young
adults with recent-onset schizophrenia: a randomized con-
trolled trial. Psychol Med 2012; 42: 1626–36.
51. Hettema J. E., Hendricks P. S. Motivational interviewing for
smoking cessation: a meta-analytic review. J Consult Clin
Psychol 2010; 78: 868.
52. Alterman A. I., Gariti P., Cook T. G., Cnaan A. Nicodermal
patch adherence and its correlates. Drug Alcohol Depend
1999; 53: 159–65.
53. Hollands G. J., McDermott M. S., Lindson-Hawley N., Vogt F.,
Farley A., Aveyard P. Interventions to increase adherence to
medications for tobacco dependence. Cochrane Database Syst
Rev 2015; 2: CD009164.
Supporting information
Additional Supporting Information may be found in the
online version of this article at the publisher’s web-site:
Appendix S1 Example: calculating a Bayes Factor.
Using Bayes factors for testing hypotheses about intervention effectiveness in addictions research 2247
© 2016 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction Addiction, 111, 2230–2247
